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Abstract 
This report describes the processing and certification of genomic lambda deoxyribonucleic acid (DNA) in a solution. ERM®-AD442k is certified for its 
lambda DNA mass, expressed in ng/µL. The DNA copy number concentration in cp/µL is provided as an indicative value. The material was produced 
according to ISO Guide 34:2009. 
A volume of approximately 400 mL of lambda DNA at an approximate concentration of 450 ng/µL was purchased from Promega Corporation and 
Benelux BV (Madison, USA and Leiden, NL). After homogenising and diluting this solution with TE buffer, 3100 vials of ERM-AD442k were produced. 
Each ERM-AD442k vial contains a certified DNA mass concentration of 57.53 ng/µL with an expanded combined uncertainty of 1.07 ng/µL. Using two 
different next generation sequencing (NGS) techniques (i.e. an Illumina platform and the GS Junior platform from Roche), the nucleic acid sequence of 
the lambda DNA in ERM-AD442k was verified. Non-lambda DNA sequences were identified in this material. The relative proportion of those sequences 
was estimated by NGS and further quantified by quantitative polymerase chain reaction (qPCR). Traces of the contaminating DNA, mainly coming 
from the Escherichia coli (E. coli) host used by Promega Corporation and Benelux BV to produce the lambda DNA, were negligible. 
Between-vial homogeneity was quantified and stability during dispatch and storage were assessed in accordance with ISO Guide 35:2006 . Within-vial 
homogeneity was quantified to determine the minimum sample intake. 
The certified DNA mass concentration value was obtained by ultraviolet (UV) spectrophotometry and the indicative DNA copy number concentration 
value by digital PCR (dPCR). The DNA copy number concentration measured by dPCR is consistent with the DNA mass concentration determined by UV 
spectrophotometry. The measurements were performed according to the scope of accreditation to ISO/IEC 17025:2005. 
The material was characterised by an inter-laboratory comparison exercise performed by laboratories of demonstrated competence and with 
adherence to ISO/IEC 17025. Technically invalid results were removed; however no other outliers were eliminated on statistical grounds only.  
Uncertainties of the certified and indicative values were calculated in accordance with the Guide to the Expression of Uncertainty in Measurement 
(GUM) [ ] and include uncertainties relating to possible inhomogeneity and instability, and to characterisation. 
The material and its certified value are intended to be used for the calibration of DNA quantification methods, quality control and assessment of 
method performance. As any reference material, it can also be used to establish control charts or in validation studies. The indicative value of the 
material is, in contrast to the certified value, a value where the uncertainty was deemed too large to allow certification and is therefore less reliable 
than the certified value.  
The CRM is available in Axygen maximum recovery polypropylene vial containing a nominal volume of 1.1 mL lambda DNA in solution. The minimum 
amount of sample to be used is 50 µL for UV spectrophotometry and 68 µL for dPCR. The CRM was accepted as European Reference Material (ERM®) 
after peer evaluation by the partners of the European Reference Materials consortium..  
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Summary 
This report describes the processing and certification of genomic lambda deoxyribonucleic 
acid (DNA) in a solution. ERM®-AD442k is certified for its lambda DNA mass, expressed 
in ng/µL. The DNA copy number concentration in cp/µL is provided as an indicative value. 
The material was produced according to ISO Guide 34:2009 [1]. 
A volume of approximately 400 mL of lambda DNA at an approximate concentration of  
450 ng/µL was purchased from Promega Corporation and Benelux BV (Madison, USA and 
Leiden, NL). After homogenising and diluting this solution with TE buffer, 3100 vials of  
ERM-AD442k were produced. Each ERM-AD442k vial contains a certified DNA mass 
concentration of 57.53 ng/µL with an expanded combined uncertainty of 1.07 ng/µL. Using 
two different next generation sequencing (NGS) techniques (i.e. an Illumina platform and the 
GS Junior platform from Roche), the nucleic acid sequence of the lambda DNA in  
ERM-AD442k was verified. Non-lambda DNA sequences were identified in this material. The 
relative proportion of those sequences was estimated by NGS and further quantified by 
quantitative polymerase chain reaction (qPCR). Traces of the contaminating DNA, mainly 
coming from the Escherichia coli (E. coli) host used by Promega Corporation and Benelux 
BV to produce the lambda DNA, were negligible. 
Between-vial homogeneity was quantified and stability during dispatch and storage were 
assessed in accordance with ISO Guide 35:2006 [2]. Within-vial homogeneity was quantified 
to determine the minimum sample intake. 
The certified DNA mass concentration value was obtained by ultraviolet (UV) 
spectrophotometry and the indicative DNA copy number concentration value by digital PCR 
(dPCR). The DNA copy number concentration measured by dPCR is consistent with the 
DNA mass concentration determined by UV spectrophotometry. The measurements were 
performed according to the scope of accreditation to ISO/IEC 17025:2005 [3]. 
The material was characterised by an inter-laboratory comparison exercise performed by 
laboratories of demonstrated competence and with adherence to ISO/IEC 17025. Technically 
invalid results were removed; however no other outliers were eliminated on statistical 
grounds only.  
Uncertainties of the certified and indicative values were calculated in accordance with the 
Guide to the Expression of Uncertainty in Measurement (GUM) [4] and include uncertainties 
relating to possible inhomogeneity and instability, and to characterisation. 
The material and its certified value are intended to be used for the calibration of DNA 
quantification methods, quality control and assessment of method performance. As any 
reference material, it can also be used to establish control charts or in validation studies. The 
indicative value of the material is, in contrast to the certified value, a value where the 
uncertainty was deemed too large to allow certification and is therefore less reliable than the 
certified value.  
The CRM is available in Axygen maximum recovery polypropylene vial containing a nominal 
volume of 1.1 mL lambda DNA in solution. The minimum amount of sample to be used is  
50 µL for UV spectrophotometry and 68 µL for dPCR. 
The CRM was accepted as European Reference Material (ERM®) after peer evaluation by 
the partners of the European Reference Materials consortium. 
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The following values were assigned: 
 
Lambda DNA in a solution 
 
DNA mass concentration 
Certified value 1) 
[ng/µL] 
Uncertainty 2) 
[ng/µL] 
Lambda DNA  57.5 1.1 
1)  As measured by UV spectrophotometry using an absorption coefficient for denatured DNA of 37 ng/µL (see Section 
1.3 and Equation 1 in the Certification Report), including less than 0.02 ng/µL of non-lambda DNA (i.e. E. coli DNA). 
The certified value represents the unweighted mean value of the means of accepted sets of data, each set being 
obtained in a different laboratory. The certified value and its uncertainty are traceable to the International System of 
units (SI). 
2) The uncertainty of the certified value is the expanded uncertainty with a coverage factor k = 2 corresponding to a 
level of confidence of about 95 % estimated in accordance with ISO/IEC Guide 98-3, Guide to the Expression of 
Uncertainty in Measurement (GUM:1995), ISO, 2008. 
 
The DNA copy number concentration of the lambda DNA solution is also provided as an 
indicative value with a relative expanded combined uncertainty of 14.01 %. 
 
Lambda DNA in a solution 
 
Copy number concentration 
Indicative value 1) 
[cp/µL] 
Uncertainty 2) 
[cp/µL] 
Lambda DNA  1.20 x 109 0.17 x 109  
1) As measured by digital PCR using a set of primers and probe that amplifies a specific lambda DNA fragment and 
using the conditions described in Annex Table A1 – A3 of the Certification Report. The DNA copy number 
concentration was calculated using Equation 2 in the Certification Report. The indicative value is an unweighted mean 
value of the means of accepted sets of data, each set being obtained in a different laboratory. The indicative value 
and its uncertainty are traceable to the International System of units (SI). 
2) The uncertainty of the indicative value is the expanded uncertainty with a coverage factor k = 2.36 corresponding to 
a level of confidence of about 95 % estimated in accordance with ISO/IEC Guide 98-3, Guide to the Expression of 
Uncertainty in Measurement (GUM:1995), ISO, 2008. 
 
 
 
 
 
 
 
 
 
 
 
 3 
Table of contents 
Summary .............................................................................................................................. 1 
Table of contents ................................................................................................................. 3 
Glossary ............................................................................................................................... 5 
1 Introduction .............................................................................................................. 9 
1.1 Background ............................................................................................................... 9 
1.2 Choice of the material ................................................................................................ 9 
1.3 Design of the project .................................................................................................10 
2 Participants .............................................................................................................13 
2.1 Project management and evaluation .........................................................................13 
2.2 Raw material provider ...............................................................................................13 
2.3 Processing, homogeneity and stability study .............................................................13 
2.4 Characterisation ........................................................................................................13 
3 Material processing and process control .............................................................15 
3.1 Origin/Purity of the starting material ..........................................................................15 
3.2 Processing ................................................................................................................15 
3.3 Process control .........................................................................................................18 
4 Homogeneity ...........................................................................................................22 
4.1 Between-vial homogeneity ........................................................................................22 
4.2 Within-vial homogeneity and minimum sample intake ...............................................24 
5 Stability....................................................................................................................26 
5.1 Short-term stability study ..........................................................................................26 
5.2 Long-term stability study ...........................................................................................26 
5.3 Estimation of uncertainties ........................................................................................27 
5.4 Stability after freeze-thaw cycles ...............................................................................28 
6 Characterisation .....................................................................................................29 
6.1 Selection of participants ............................................................................................29 
6.2 Study setup ...............................................................................................................29 
6.3 Methods used ...........................................................................................................30 
6.4 Evaluation of results .................................................................................................30 
6.4.1 Technical evaluation .................................................................................................30 
6.4.2 Statistical evaluation .................................................................................................31 
7 Value Assignment ...................................................................................................33 
7.1 Certified value and its uncertainty .............................................................................33 
7.2 Indicative value and its uncertainty ...........................................................................34 
8 Metrological traceability and Applicability of CRM ..............................................35 
8.1 Metrological traceability ............................................................................................35 
8.2 Applicability of CRM ..................................................................................................35 
9 Instructions for use ................................................................................................37 
9.1 Safety information .....................................................................................................37 
4 
 
9.2 Storage conditions ....................................................................................................37 
9.3 Preparation and use of the material ..........................................................................37 
9.4 Minimum sample intake ............................................................................................37 
9.5 Use of the certified value ..........................................................................................37 
10 Acknowledgments ..................................................................................................39 
11 References ..............................................................................................................40 
 5 
Glossary 
A Adenine 
260A  Absorbance of DNA at 260 nm wavelength 
320A  Background absorbance at 320 nm wavelength 
ANOVA  Analysis of variance 
b Slope in the equation of linear regression y = a + bx 
BHQ1 Black Hole Quencher 1 
BLAST Basic Local Alignment Search Tool 
bp Base pair 
c Mass concentration c = m / V (mass / volume) 
C Cytosine 
Cl Confidence level 
Ct Threshold of cycle 
CRM Certified reference material 
DNA Deoxyribonucleic acid 
dsDNA Double-stranded DNA 
ε
 Absorption coefficient 
E. coli Escherichia coli 
EDTA Ethylenediaminetetraacetic acid 
ERM® Trademark of European Reference Materials 
FAM Fluorescein amidite 
G Guanine 
GC Guanine Cytosine 
GUM Guide to the Expression of Uncertainty in Measurements [4] 
IRMM Institute for Reference Materials and Measurements of the JRC  
ISO International Organization for Standardization  
JRC Joint Research Centre of the European Commission 
k Coverage factor 
M Molar mass 
MSbetween Mean of squares between-vial from an ANOVA 
MSwithin  Mean of squares within-vial from an ANOVA 
DNAMW  Molecular weight of DNA 
n.a. Not applicable 
NCBI National Center for Biotechnology Information 
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NGS Next generation sequencing 
PCR Polymerase chain reaction 
dPCR Digital PCR 
qPCR Quantitative PCR 
rel Index denoting relative figures (uncertainties etc.) 
RNA Ribonucleic acid 
RSD Relative standard deviation 
r2 Coefficient of determination of the linear regression 
s Standard deviation 
sbb
 Between-vial standard deviation; an additional index "rel" is added when 
appropriate 
sbetween Standard deviation between groups as obtained from ANOVA; an 
additional index "rel" is added as appropriate 
SI International System of Units 
ssDNA Single-stranded DNA 
swithin Standard deviation within groups as obtained from ANOVA; an additional 
index "rel" is added as appropriate 
t Time 
T Thymine 
TaqMan® Thermus aquaticus (Taq) DNA polymerase-based technology for 
fluorescent signal generation during real-time PCR 
TE Buffer containing TRIS and EDTA 
TRIS Tris(hydroxymethyl)aminomethane 
u Standard uncertainty  
U Expanded uncertainty 
u*bb  Standard uncertainty related to a maximum between-vial inhomogeneity 
that could be hidden by method repeatability; an additional index "rel" is 
added as appropriate 
ubb Standard uncertainty related to a possible between-vial inhomogeneity;  
an additional index "rel" is added as appropriate 
uchar  Standard uncertainty of the material characterisation; an additional index 
"rel" is added as appropriate 
uCRM Combined standard uncertainty of the certified value; an additional index 
"rel" is added as appropriate 
UCRM  Expanded uncertainty of the certified value; an additional index "rel" is 
added as appropriate 
u∆ Combined standard uncertainty of measurement result and certified 
value 
ults Standard uncertainty of the long-term stability; an additional index "rel" is 
added as appropriate 
Umeas Expanded measurement uncertainty 
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usts Standard uncertainty of the short-term stability; an additional index "rel" 
is added as appropriate 
UV Ultraviolet 
∆meas Absolute difference between mean measured value and the certified 
value 
MSwithinν
 
Degrees of freedom of MSwithin 
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1 Introduction  
1.1 Background 
Precise quantification of DNA is needed to optimise molecular techniques such as PCR, 
microarrays or NGS. Lambda DNA is frequently and widely used as a calibrant for 
measurements quantifying the mass of an extracted DNA in solution. Restricted lambda DNA 
fragments are also used as molecular markers for electrophoretic techniques such as gel or 
capillary electrophoresis. Popular DNA quantification kits, for example the Quant-iTTM 
PicoGreen® dsDNA Assay Kit (Life Technologies) and the DNAQF quantification kit (Sigma-
Aldrich), rely on a calibration curve constructed with a lambda DNA standard to determine 
the DNA mass of an unknown sample. However, the DNA mass in such a standard is not a 
certified value and can vary from one lot to another. Consequently, potential bias in the DNA 
mass measurements could occur, leading to distorted results. Therefore, a reference 
material (RM) certified for its lambda DNA mass was needed.  
For this purpose, the mass of the lambda DNA has been accurately determined by inter-
laboratory comparison study, the lambda DNA mass variation from vial to vial and its stability 
investigated. Additionally the lambda DNA has been checked for its identity and purity and a 
certified value was established. The methods used to quantify the lambda DNA mass have 
different dynamic ranges. The UV spectrophotometric methods allow the quantification of 
DNA at a higher range (up to mg/µL), whereas dPCR methods can only quantify low 
concentration of DNA molecules (up to fg/µL) [5,6,7,8]. When applying dPCR methods, the 
sample had first to be highly diluted before being measured. 
 
1.2 Choice of the material 
Phage lambda, a virus that infects the bacterial species E. coli., is often chosen as a 
calibrant for DNA quantification measurements because it is a well-studied organism. 
Numerous scientific publications about phage lambda, its infection mechanism and its 
replication mechanism have been published [9,10,11,12,13]. The phage lambda particle is 
composed of a head, a tail and tail fibres. The genome of phage lambda consists of 1 
chromosome, has a guanine-cytosine (GC) content of 49.9 % and 92 genes that encode 73 
proteins. The lambda DNA chromosome is located in the head of the virus particle in its 
linear state, and has a double-stranded segment of 48490 bp and a single-stranded segment 
of 12 bp at the 5’ site of both strands (called cos sites). When phage lambda infects its host 
E. coli, both cos sites of the chromosome anneal to each other and form a circular double-
stranded phage DNA with a length of 48502 bp [12]. The reference sequence of phage 
lambda is established in the databank of the National Center for Biotechnology Information 
(NCBI, http://www.ncbi.nlm.nih.gov/) of which the RefSeq number is NC_001416.1. Based on 
this reference sequence, primers and probe for dPCR assays can be designed [7].  
The fact that phage lambda has a relatively high infection capability to E. coli and a high 
replication mechanism in E. coli [12,13,14], together with the easy and straightforward 
manipulation of E. coli in laboratories for different purposes (e.g. in-vitro mutagenesis, 
cloning process) [15,16,17,18], enables the production of large quantities of lambda DNA. 
Consequently, it was decided to use lambda DNA as material for ERM-AD422k. The lambda 
DNA used for production was purchased from Promega Corporation and Benelux BV 
(Madison, USA and Leiden, NL).  
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1.3 Design of the project 
 
1.3.1 Methods 
During the homogeneity, the stability and the characterisation studies, UV spectrophotometry 
and dPCR were used to determine the DNA mass concentration and the DNA copy number 
concentration (respectively). The vials for each study were selected using a random stratified 
sampling scheme which covered the whole batch.  
 
1.3.1.1 UV spectrophotometry 
UV spectrophotometry measures the intensity of light passing through a sample and 
compares it to the intensity of light of a blank solution. The intensity of this relative UV 
absorption will depend on the amount of macromolecules in the measured sample solution 
and is used as an indirect quantification method. The presence of RNA, proteins, single 
nucleotides, chemical and other components that also absorb UV light will bias the 
quantification of DNA. A mixture of denatured and undenatured DNA molecules in solution 
will also bias the DNA mass determination as dsDNA and ssDNA have different absorption 
coefficients (ε). To avoid the latter, dsDNA is completely denatured into ssDNA prior to the 
measurement by UV spectrophotometry. The DNA mass concentration is calculated using an 
absorption coefficient of 37 ng/µL [19] for ssDNA and based on Lambert-Beer law [20] (see 
Equation 1). 
( ) DNA320260DNA DAAc ×−×= ε    Equation 1 
DNAc  DNA mass concentration [ng/µL] 
ε
 Absorption coefficient ( =ε 37 ng/µL for ssDNA) 
260A  Absorbance of DNA at 260 nm wavelength 
320A  Background absorbance at 320 nm wavelength 
DNAD  Dilution factor of the DNA mass concentration 
 
In these studies, UV spectrophotometrical measurements were performed with denatured 
lambda DNA which was diluted 5 times gravimetrically with T1E0.01 buffer (1 mmol/L 
tris(hydroxymethyl)aminomethane [TRIS] and 0.01 mmol/L ethylenediamine tetraacetic acid 
[EDTA] at pH 8.0) and with NaOH that had a final concentration of 0.2 M. Absorbance at the 
wavelength of 230 nm (A230), 260 nm (A260), 280 nm (A280) and 320 nm (A320) were measured 
in a volume of 100 µL. Each vial was analysed in triplicate. The DNA purity was found 
acceptable if the A260/A280 ratio was between 1.8 and 2.0 and if the A260/A230 ratio was 
between 2.0 and 2.2. 
 
1.3.1.2 Digital PCR 
In the digital PCR array used for this study, the samples were distributed in several panels 
containing each a large number of partitions. A PCR was carried out in each individual 
partition. If a target DNA sequence is present in a partition, it will be eventually amplified and 
generate a fluorescent signal that is measured by a digital camera. The ratio between 
positive (H) and total number of partitions (C) was used to estimate the amount of target 
DNA sequence present in the original solution (Tc). Poisson approximation, using a binomial 
distribution, is applied for those partitions that contain more than one target DNA sequence 
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(Equation 2 [6]). To ensure an homogenous distribution of the target DNA over a panel, 
enzymatic digestion of the DNA prior to PCR was performed. 
The copy number concentration (Tc) is calculated as follows: 












−












−
×





=
C
C
H
V
D
T FC 11log
1log
   Equation 2 
CT  Copy number concentration [cp/µL] 
FD  Final dilution factor of the original undigested DNA sample 
V  Volume of a panel  
H  Number of partitions with a positive PCR signal 
C  Number of total analysed partitions 
 
The BioMark™ HD System and the BioMarkTM 12.765 Digital Arrays (both from Fluidigm, 
South San Francisco, US) were used for analysing ERM-AD442k in the homogeneity, the 
stability and the characterisation studies. A 12.765 Digital Array is composed of 12 panels, of 
which each has 765 partitions. One partition has an estimated reaction volume of 6.01 nL. 
The total estimated volume per panel (V ) is 4.597 µL.  
 
The simplex dPCR assay for lambda DNA was derived from Bhat et al. [7]. The primers and 
the probe target a region of the lambda DNA that has a GC content of around 60 % [7]. The 
probe is labelled at the 5’ end with 6-FAM (fluorescein amidite) and at the 3’ end with the 
Black Hole Quencher 1 (BHQ1). Using the Basic Local Alignment Search Tool (BLAST) 
version 2.2.29+ from NCBI, the sequence of the primers and probe were analysed against 
the phage lambda reference sequence (NC_001416.1) and an E. coli database. The primers 
and probe had 100 % of nucleic acid sequence identity with the phage lambda reference 
sequence.  
TaqMan® Universal PCR MasterMix (2x) (Applied BioSystems, Lennik, BE) and 20x GE 
sample loading reagent (Fluidigm) were used in the dPCR assay. Details of the primers and 
probe and the dPCR conditions are described in Annex Table A1 – A3.  
Lambda DNA in each vial was digested with restriction enzyme Taq(α)I (New England 
Biolabs, Leiden, NL), followed by qualitative analysis using gel electrophoresis. The digested 
lambda DNA was gravimetrically diluted into 2 independent dilution series, each targeting a 
nominal final DNA copy number concentration of 447 cp/µL [6,7]. In total, there were 8 
dilution steps (from the digestion step to the step of the reaction mix), resulting in a dilution 
factor of about 10 million. In each dilution series, digested lambda DNA was measured 5 
times. The replicates were spread at random over different BioMark™ 12.765 digital arrays. 
The results were analysed using the Fluidigm Digital PCR Analysis software. 
 
1.3.2 Studies 
Several studies were performed including homogeneity, short-term stability, long-term 
stability and characterisation studies. The details of these studies are described in the 
Section 4, 5 and 6. Since the DNA could be fragmentised after freeze-thaw cycles, the 
consistency of the DNA mass concentration of ERM-AD442k was analysed by UV 
12 
 
spectrophotometry after up to 10 cycles of freezing and thawing (see Section 5.4). Sequence 
identification analysis and purity assessment were also performed (see Section 3.3.2). 
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2 Participants 
2.1 Project management and evaluation 
European Commission, Joint Research Centre, Institute for Reference Materials and 
Measurements (IRMM), Geel, BE  
(accredited to ISO Guide 34 for production of certified reference materials, BELAC No. 268-RM) 
 
2.2 Raw material provider  
Promega Corporation, Madison, USA 
Promega Benelux BV, Leiden, NL 
 
2.3 Processing, homogeneity and stability study 
European Commission, Joint Research Centre, Institute for Reference Materials and 
Measurements (IRMM), Geel, BE  
(accredited to ISO Guide 34 for production of certified reference materials, BELAC No. 268-RM)  
 
2.4 Characterisation 
2.4.1 Sequence identity of lambda DNA and purity assessment 
Baseclear BV, Leiden, NL 
Eurofins Medigenomix GmbH, Ebersberg, DE 
(measurements under the scope of ISO/IEC 17025 accreditation DAkkS, accreditation number  
D-PL-13372-01-00) 
European Commission, Joint Research Centre, Institute for Reference Materials and 
Measurements (IRMM), Geel, BE  
 
2.4.2 UV spectrophotometry measurement (DNA mass concentration) 
European Commission, Joint Research Centre, Institute for Reference Materials and 
Measurements (IRMM), Geel, BE  
European Commission, Joint Research Centre, Institute for Health and Consumer Protection 
(IHCP), Ispra, IT 
LGC Limited, Science and Innovation, Molecular and Cell Biology, Teddington, UK 
Livsmedelsverket, Science Department, Uppsala, SE 
National Institute of Biology (NIB), Department of Biotechnology and Systems Biology, 
Ljubljana, SI 
National Measurement Institute (NMI), Department of Industry, Innovation, Science, 
Research and Tertiary Education, Bioanalysis Group, Lindfield, AU 
Solvias AG, Kaiseraugst, CH 
 
2.4.3 Digital PCR measurements (DNA copy number concentration) 
European Commission, Joint Research Centre, Institute for Reference Materials and 
Measurements (IRMM), Geel, BE 
14 
 
European Commission, Joint Research Centre, Institute for Health and Consumer Protection 
(IHCP), Ispra, IT 
LGC Limited, Science and Innovation, Molecular and Cell Biology, Teddington, UK 
National Institute of Biology (NIB), Department of Biotechnology and Systems Biology, 
Ljubljana, SI 
National Measurement Institute (NMI), Department of Industry, Innovation, Science, 
Research and Tertiary Education, Bioanalysis Group, Lindfield, AU 
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3 Material processing and process control 
3.1 Origin/Purity of the starting material 
Lambda DNA (lot number 0000015651, part number D152X) was purchased from Promega 
Corporation and Benelux BV. For the lambda DNA starting material production, E. coli K-12 
GM119 strain was infected with cI857 Sam7 phage lambda. When this phage lambda 
reached its lytic state in the host, phage lambda particles were isolated and unmethylated 
lambda DNA was extracted from this isolate via several purification steps. In the cI857 Sam7 
lambda DNA strain, there are 4 known mutations that are annotated in the NCBI reference 
sequence NC_001416.1 and that are summarised in Table 1. 
 
Table 1. Four known mutations in the cI857 Sam7 lambda DNA strain.  
Gene Position in the reference sequence Reference nucleotide Mutation 
ind1 37589 C T 
cI857 37742 C T 
NinH 43082 G A 
Sam7 45352 G A 
 
During the production of the lambda DNA starting solution, Promega Corporation and 
Benelux BV performed quality control tests checking for the presence of proteins, chemical 
residues and nucleases. The results showed absence of these components in the lambda 
DNA starting solution. The unmethylated status of the lambda DNA was also confirmed by 
Promega Corporation and Benelux BV. 
A volume of approximately 400 mL of buffered solution (10 mM Tris-HCl, 1 mM EDTA and 10 
mM NaCl, pH of 7.5) containing lambda DNA at an estimated DNA mass concentration of 
450 ng/µL was purchased from Promega Corporation and Benelux BV. The lambda DNA 
starting solution was shipped cooled and stored at 4 °C until processing. 
 
The sequence identity and purity of the lambda DNA were analysed using NGS techniques, 
by two independent expert sequencing service companies. Two different NGS platforms 
were used: 1) Illumina and 2) GS Junior with Titanium series chemistry from Roche. The 
results of the NGS and qPCR analyses are given in Section 3.3.2.3. Nevertheless non-
lambda (i.e. E. coli) DNA sequences were found in a very small amount and further 
quantification of these non-lambda DNA sequences was performed using qPCR. A negligible 
amount of E. coli DNA sequences was quantified. 
 
3.2 Processing 
DNA can aggregate and become viscous [21,22], therefore care needs to be taken to avoid 
inhomogeneous distribution of the DNA mass concentration between vials. To reduce the 
viscosity and the possibility of the aggregation of the lambda DNA, a nominal target DNA 
mass concentration of 50 ng/µL was chosen for the production of ERM-AD442k. A method 
for homogenising the lambda DNA solution was developed and assessed. Prior to the 
processing of ERM-AD442k, several tests were performed to determine the optimal 
conditions for the processing of the CRM, concerning e.g. the incubation temperature, 
16 
 
measures to avoid the formation of DNA aggregates and sedimentation. The optimal 
processing conditions, including the silanisation of glass bottles, were identified and applied 
in the processing of ERM-AD442k, as described in this Section. The processing scheme of 
ERM-AD442k is shown in Figure 1. 
 
 
Figure 1. Processing scheme of ERM-AD442k. 
 
3.2.1 Homogenising of the lambda DNA starting solution 
The purchased lambda DNA starting solution was homogenised by incubating statically at  
37 °C for 4 h, followed by a mixing step using Dynamix CM200 3D mixer (WAB, Basel, CH) 
at 23 °C for 3 h. At 3 depth levels of the solution (i.e. at the top, the middle and the bottom of 
the solution), a volume of approximately 50 µL was sampled to assess the DNA mass 
concentration of the solution with UV spectrophotometry using a NanoDrop 1000 
spectrophotometer (Thermo Scientific, Wilmington, US). Absorbances at the 230 nm (A230), 
260 nm (A260) and 280 nm (A280) wavelength were measured. The DNA mass concentration 
was automatically calculated by the software of the NanoDrop 1000 spectrophotometer 
(Thermo Scientific), using an absorption coefficient of 50 ng/µL for dsDNA. The results are 
presented in Table 2. The average DNA mass concentration of all 3 depth levels of the 
lambda DNA starting solution was 450.8 ng/µL and its standard deviation was 3.7 ng/µL. The 
average ratio of A260/A280 was 1.88 ± 0.01 and the average A260/A230 ratio was 2.01 ± 0.01. 
Both ratios were in the acceptable DNA purity range. However, these values do not exclude 
traces of contaminating proteins or chemical residues from the host co-purified with the 
lambda DNA. 
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Table 2. Homogeneity test on the DNA mass concentration (cDNA) of the lambda DNA starting 
solution after mixing. s: standard deviation 
Intake location 
in the lambda 
DNA starting 
solution  
Number of 
replicates 
Mean cDNA ± s 
[ng/µL] 
Mean A260/A280 ± s 
[A] 
Mean A260/A230 ± s 
[A] 
top 3 449.1 ± 2.0 1.88 ± 0.01 2.01 ± 0.01 
middle 3 454.5 ± 3.7 1.88 ± 0.01 2.01 ± 0.01 
bottom 3 448.8 ± 2.6 1.88 ± 0.01 2.01 ± 0.01 
 
The data were evaluated using a one-way analysis of variance (ANOVA). No significant 
difference between depth levels was observed at a confidence level of 99 %, indicating that 
the DNA mass concentration of the lambda DNA starting solution was homogenous. The 
degradation of the lambda DNA in the starting solution after mixing was assessed using gel 
electrophoresis with 1 % ethidium bromide-stained agarose gel. No DNA degradation was 
observed (data not shown). 
 
3.2.2 Preparation of lambda DNA stock solution for filling  
The lambda DNA starting solution was found to be homogeneous and after its DNA mass 
concentration was determined, a lambda DNA stock solution was prepared by diluting to a 
nominal DNA mass concentration of 50 ng/µL with sterilised T1E0.01 buffer. This results in a 
volume of approximately 3600 mL ready for the preparation of the CRMs. A silanised glass 
bottle was used for the lambda DNA stock preparation to minimise the DNA adsorption to 
glass. The bottle of the stock solution was inverted 10 times, before mixing by the Dynamix 
CM200 3D mixer at 23 °C for 3 h. At 4 depths of the stock solution (i.e. top, upper middle, 
lower middle and bottom), a 100 µL volume of lambda DNA stock solution was sampled for a 
homogeneity check using UV spectrophotometry, as above (Table 3). The average DNA 
mass concentration of all 4 depth levels of the stock solution was 59.4 ng/µL with a standard 
deviation of 0.8 ng/µL. The average ratio of A260/A280 was 1.94 ± 0.04 and the average ratio 
of A260/A230 was 2.16 ± 0.05. Both ratios were in the acceptable DNA purity range. Both ratios 
increased mildly in comparison with the ratios in Table 2, due to an increased proportion of 
T1E0.01 buffer to lambda DNA in the stock solution. The A260/A280 ratio indicates that the 
amount of contaminants in the lambda DNA starting solution was higher than in the stock 
solution. 
 
Table 3: Homogeneity test on the DNA mass concentration (cDNA) of the lambda DNA stock 
solution after mixing. s: standard deviation 
Intake location 
in the lambda 
DNA stock 
solution 
Number of 
replicates 
Mean cDNA ± s 
[ng/µL] 
Mean A260/A280 ± s 
[A] 
Mean A260/A230 ± s 
[A] 
top 3 58.7 ± 0.6 1.93 ± 0.03 2.19 ± 0.03 
upper middle 3 59.2 ± 0.5 1.97 ± 0.04 2.12 ± 0.03 
lower middle 3 60.4 ± 0.9 1.95 ± 0.06 2.24 ± 0.03 
bottom 3 59.4 ± 0.3 1.91 ± 0.02 2.15 ± 0.03 
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The data was evaluated using a one-way ANOVA. No significant difference between depth 
levels was observed at a confidence level of 99 %, indicating the DNA mass concentration of 
the lambda DNA stock solution was homogeneous. The degradation of the lambda DNA in 
the stock solution after mixing was assessed using gel electrophoresis with 1 % ethidium 
bromide-stained agarose gel. No DNA degradation was observed (data not shown). 
 
3.2.3 Preparation of individual lambda DNA CRMs 
Once the homogeneity of the lambda DNA mass concentration in the stock solution was 
confirmed, 3100 sterile Axygen maximum recovery polypropylene vials (Corning, Tewksbury 
MA, US) were filled using semi-automated Opus® dispensers (Hirschmann Laborgeräte 
GmbH & Co. KG, Eberstadt, DE) under sterile conditions. The nominal filling volume was set 
to 1.1 mL per vial. After filling, all vials were tightly closed manually and checked visually to 
ensure correct filling.  
Subsequently, vials for the homogeneity study, the stability studies, the characterisation 
study, the identification investigation, the purity assessment and the freeze-thaw 
investigation were selected according to a random stratified sampling scheme which covered 
the entire batch. The ERM-AD442k vials were stored at -20 ± 5 °C (i.e. the storage 
temperature). 
 
3.3 Process control  
 
During the processing of ERM-AD442k, the following aspects were investigated. 
 
3.3.1 Production of individual lambda DNA CRMs 
At IRMM the lambda DNA starting and stock solutions were mixed and analysed for their 
homogeneity concerning their DNA mass concentration using UV spectrophotometry. The 
DNA degradation was assessed using gel electrophoresis. This was followed by the filling of 
individual vials with lambda DNA in solution. The DNA mass concentration of both lambda 
DNA starting and stock solutions was homogeneous and the DNA in both solutions was not 
degraded prior to the filling of the vials (see Sections 3.2.1 and 3.2.2). 
 
3.3.2 Sequence identification, molecular weight establishment and purity assessment 
Two sequencing service companies used NGS techniques to determine the full nucleic acid 
sequence of the lambda DNA and to assess the purity of ERM-AD442k. Two different NGS 
techniques were used: Illumina NGS platform based on base-specific fluorescent 
sequencing, and GS Junior platform together with Titanium series chemistry (Roche) based 
on the pyrosequencing.  
 
3.3.2.1 Sequence identification 
The sequences obtained by both NGS techniques were compared to each other and to the 
phage lambda reference sequence in NCBI (NC_001416.1). Both NGS sequences were 
confirmed to be homologous to the lambda DNA sequence. The consensus sequence results 
in a lambda DNA sequence with a length of 48502 bp. A sequencing artefact was considered 
when a sequenced fragment did not align to the reference sequence and a variant in a 
sequence was considered as a true variant, when it occurred in both sequences and not in 
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the reference sequence (data not shown). Four variants were found to be true variants and 
are equal to the four previous known mutations listed in Table 1.  
 
3.3.2.2 Molecular weight establishment 
Based on the obtained assembled sequence from both NGS techniques, the molecular 
weight of the unmethylated lambda DNA in ERM-AD442k was established using Equation 3, 
resulting in a molecular weight of 29969028.65 g/mol. 
( ) ( ) ( ) ( )[ ] ( )[ ]{ } 2M1nMnMnMnMnMW OHntdTMPTdAMPAdGMPGdCMPCDNA 2 ××−−×+×+×+×=
            Equation 3 
Cn   Number of cytosine per single-stranded DNA  
dCMPM  Molar mass of deoxycytidine monophosphate (dCMP) 
Gn   Number of guanine per single-stranded DNA  
dGMPM  Molar mass of deoxyguanosine monophosphate (dGMP) 
An   Number of adenine per single-stranded DNA  
dAMPM  Molar mass of deoxyadenosine monophosphate (dAMP) 
Tn   Number of thymine per single-stranded DNA  
dTMPM  Molar mass of deoxythymidine monophosphate (dTMP) 
ntn   Number of nucleotides in a single-stranded DNA 
OHM 2  Molar mass of water 
 
The molar mass of nucleotide monophosphate (i.e. dCMP, dGMP, dAMP and dTMP) was 
calculated as diprotonated acid (i.e. as H2PO3). The molar mass of the nucleotide 
monophosphates and of water used in Equation 3 are displayed in Table 4. The accurate 
mass information was obtained from the National Institute of Standards and Technology 
(NIST) website: http://physics.nist.gov/PhysRefData/Compositions/index.html  
(Date created: August 23, 2009 Ɩ Last updated: February 3, 2015) 
 
Table 4. Molar mass of the nucleotide monophosphates and of water (used in  
Equation 3) 
Nucleotide monophosphate/water Chemical composition Molar mass [g/mol] 
dCMP C9H14N3PO7 307.20 
dGMP C10H14N5PO7 347.22 
dAMP C10H14N5PO6 331.22 
dTMP C10H15N2PO8 322.21 
Water H2O 18.02 
 
The established molecular weight of the lambda DNA in ERM-AD442k enables the 
conversion from DNA copy number concentration (obtained from dPCR analysis) into a DNA 
mass concentration (see Equation 4) and vice versa. 
A
9
DNAC
N
10MWT
c
××
=          Equation 4 
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c
 DNA mass concentration [ng/µL] 
CT  Copy number concentration in the original undigested DNA sample [cp/µL] 
DNAMW  Molecular weight of DNA 
AN  Avogadro constant (6.02214129 x 1023 mol-1) 
 
 
3.3.2.3 Purity assessment 
The purity of ERM-AD442k was assessed using NGS techniques. All sequences were 
identified as being derived from either the lambda DNA or from contaminating DNA coming 
from the host. Because NGS is not a quantitative method, the amount of DNA sequences 
was roughly estimated based on the sequencing depth of coverage ratio for both DNA 
sequences. The proportion of non-lambda DNA (i.e. the host E. coli DNA) sequences to 
lambda DNA sequence was approximately 0.02 % (see Equation 5).   






×





=
lambdaDNA
hostDNA
lambdaDNA
hostDNA
NGS d
d
n
n
ι
     Equation 5 
 
NGSι   Estimated impurity of host (i.e. E. coli) DNA by NGS [%] 
hostDNAn   Number of sequenced bp of the host DNA 
lambdaDNAn   Number of sequenced bp of the lambda DNA 
hostDNAd  Sequencing depth of coverage of the host DNA sequences 
lambdaDNAd  Sequencing depth of coverage of the lambda DNA sequence 
 
To verify that these impurity traces were indeed derived from the host, two sets of primers 
and probes were designed for simplex qPCR assays based on the E. coli DNA sequences in 
the NGS data (named E. coli assay 1 and 2), using the software Primer Express software 
v.3.0.1 (Applied BioSystems). Additionally, two sets of primers and probe were designed to 
amplify a lambda DNA fragment in a simplex qPCR (named lambda DNA assay 1 and 2) [7]. 
The sequence details of the primer and probe to amplify lambda DNA and  
E. coli sequence fragments in the purity assessment are shown in Annex A. 
Five ERM-AD442k vials were randomly selected from the whole batch for qPCR analysis, 
using ABI Prism 7900HT (Applied BioSystems). Each vial was analysed in triplicate using 
lambda DNA assay 1 and 2 and E. coli assay 1 and 2. The same amount of ERM-AD442k 
lambda DNA was used in each of the four qPCR assays. The differences in Ct values 
between the lambda DNA assays and the E. coli assays were averaged and the proportion of 
E. coli DNA trace sequences in the lambda DNA solution was calculated using Equation 6. A 
percentage of impurity of 0.13 % was calculated which is in the same range as the impurity 
percentage estimated by the relative sequencing depth of coverage of both DNA. 






=
CtqPCR 2
1
∆
ι     Equation 6 
qPCRι  Quantified impurity of host (i.e. E. coli) DNA by qPCR [%] 
Ct∆   Average of Ct value differences 
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Both techniques provide an indication of the impurity level in ERM-AD442k. Since the DNA 
copy number concentration of the lambda DNA based on dPCR is known, this percentage 
can be used to determine the DNA copy number concentration of the contaminating E. coli 
DNA sequences. Therefore the observed DNA copy number concentration of 
1.57 x 106 cp/µL of the host DNA sequences can be further converted in DNA mass 
concentration. Moreover, knowing the size of the contaminating host DNA sequences (i.e. 
12641 bp), a molecular weight of 7811108.86 g/mol was calculated for the host DNA 
sequences using Equation 3. A DNA mass concentration of 0.02 ng/µL was calculated for the 
host DNA sequences (see Equation 4). 
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4 Homogeneity 
A key requirement for any certified reference material aliquoted into vials is the equivalence 
of the certified property between those vials. In this respect, it is relevant whether the 
variation between vials is significant compared to the uncertainty of the certified value. 
Consequently, ISO Guide 34 requires RM producers to quantify the between-vial variation. 
This aspect is covered in between-vial homogeneity studies. 
The within-vial inhomogeneity does not influence the uncertainty of the certified value when 
the minimum sample intake is respected, but determines the minimum size of an aliquot that 
is representative for the whole vial. Quantification of within-vial inhomogeneity is therefore 
necessary to determine the minimum sample intake. 
 
4.1 Between-vial homogeneity 
The between-vial homogeneity was evaluated to ensure that the certified and indicative 
values of the CRM are valid for all 3100 vials of the material, within the stated uncertainty. 
The number of vials selected corresponds to approximately the cubic root of the total number 
of the vials produced and therefore 20 vials were selected using a random stratified sampling 
scheme covering the whole batch. For this, the batch was divided into 20 groups (each with a 
similar number of vials) and then one vial was selected randomly from each group. The 
content of each of these vials was measured 3 times by UV spectrophotometry under 
denatured conditions (as described in Section 1.3). They were also analysed by a simplex 
dPCR assay 10 times, 5 times per dilution series (according to Section 1.3). The 
measurements by UV spectrophotometry and dPCR were performed under repeatability 
conditions and in a randomised manner to be able to separate a potential analytical drift from 
a trend in the filling sequence.  
 
4.1.1 Evaluation of trends in analytical and filling sequence 
Regression analyses were performed to evaluate potential trends in the analytical sequence 
as well as trends in the filling sequence.  
The correction of biases, even if they are statistically not significant, was found to combine 
the smallest uncertainty with the highest probability to cover the true value [23]. Correction of 
trends is therefore expected to improve the sensitivity of the subsequent statistical analysis 
through a reduction in analytical variation without masking potential between-vial 
heterogeneities. If the analytical sequence and the vial numbers are not correlated, trends 
significant on at least a 95 % confidence level can be corrected.  
In the UV spectrophotometry and dPCR analyses, no trends in the filling sequence were 
observed. Whilst no trend in the analytical sequence was observed in the dPCR analyses, a 
trend in the analytical sequence was present in the UV spectrophotometry analyses (95 % 
confidence level). After removing one technical outlier (due to an air bubble), the analytical 
trend remained. The analytical trend was corrected according to Equation 7:  
ibxx ⋅−= mc
      
Equation 7 
xc = corrected result 
xm = measured result 
b = slope of the linear regression 
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i = position of the result in the analytical sequence 
 
4.1.2 Statistical evaluation of datasets 
The trend-corrected UV spectrophotometry dataset and the dPCR dataset were assessed for 
consistency using Grubbs outlier tests at a confidence level of 99 % on the individual results 
and the unit means. No outlying individual result and no outlying unit mean in the dataset of 
UV spectrophotometry and of dPCR were detected. The results of both techniques are 
shown in Annex B. 
 
Quantification of between-vial inhomogeneity for the UV spectrophotometry was undertaken 
by analysis of variance (ANOVA), which can separate the between-vial variation (sbb) from 
the within-vial variation (swb). The latter is equivalent to the method repeatability if the 
individual samples are representative for the whole vial. In dPCR analysis, because of the 
two independent dilution series, 2-way ANOVA with replication was performed.  
Evaluation by ANOVA requires vial means which follow at least a unimodal distribution and 
results for each vial that follow unimodal distributions with approximately the same standard 
deviations. Distribution of the vial means was assessed using histograms and normal 
probability plots. Minor deviations from unimodality of the individual values do not 
significantly affect the estimate of between-vial standard deviations.  
It should be noted that sbb,rel and swb,rel are estimates of the true standard deviations and are 
subject to random fluctuation. Therefore, the mean square between groups (MSbetween) can 
be smaller than the mean square within groups (MSwithin), resulting in negative arguments 
under the square root used for the estimation of the between-vial variation, whereas the true 
variation cannot be lower than zero. In this case, u*bb, the maximum inhomogeneity that could 
be hidden by method repeatability, was calculated as described by Linsinger et al. [24]. u*bb is 
comparable to the limit of detection of an analytical method, yielding the maximum 
inhomogeneity that might be undetected by the given study setup.  
 
Method repeatability (swb,rel), between–vial standard deviation (sbb,rel) and u*bb,rel for UV 
spectrophotometry were calculated as:  
y 
MS
s
within
rel,wb =  Equation 8 
y
n
MSMS
s
withinbetween
rel,bb
−
=  Equation 9 
y
ν
2
n
MS
u
4
MSwithin
within
*
rel,bb =   Equation 10 
 
withinMS  mean square within a vial from an ANOVA  
betweenMS  mean square between-vial from an ANOVA 
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y  mean of all results of the homogeneity study 
n
 mean number of replicates per vial 
MSwithinν  degrees of freedom of MSwithin  
 
Method repeatability (swb,rel) and between–vial standard deviation (sbb,rel) for dPCR were 
calculated as:  
y 
MSMS
s
withineractionint
rel,wb
+
=
 Equation 11 
 
y
N
MSMSMS
s
withineractionintbetween
rel,bb
−−
=  Equation 12 
betweenMS  mean square between-vial from an ANOVA 
eractionintMS  mean square interaction from an ANOVA 
withinMS  mean square within a vial from an ANOVA  
N  number of vials 
y  mean of all results of the homogeneity study 
 
The results of the evaluation of the between-vial variation are summarised in Table 5. 
 
Table 5: Results of the homogeneity study 
Method  
swb,rel  
[%]
 
sbb,rel  
[%]
 
u*bb,rel 
[%] 
ubb,rel 
[%] 
UV spectrophotometry 0.99 0.58 0.27 0.58 
dPCR 11.42 1.75 1.18 1.75 
 
The homogeneity study showed no outlying vial means or trends in the filling sequence for 
the UV spectrophotometry and the dPCR methods. Therefore, the between-vial standard 
deviation could be used as an estimate of ubb for UV spectrophotometry as well as for dPCR. 
As u*bb sets the limits of the study to detect inhomogeneity, the larger value of sbb and u*bb is 
adopted as uncertainty contribution to account for potential inhomogeneity. 
 
4.2 Within-vial homogeneity and minimum sample intake 
The minimum sample intake is the minimum amount of sample that is representative for the 
whole vial and thus can be used in an analysis. The within-vial homogeneity is correlated to 
the minimum sample intake and therefore it follows that individual aliquots of a material, 
below the minimum sample intake will not contain the same amount of analyte. Sample sizes 
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equal or above the minimum sample intake guarantee the certified and the indicative value 
within its stated uncertainty. The minimum sample intake can be obtained from a dedicated 
study investigating a series of sample intakes or from the homogeneity/stability studies using 
a specific sample intake.   
 
4.2.1 UV spectrophotometry 
A dedicated minimum sample intake study was performed for UV spectrophotometry. To 
estimate the minimum sample intake, a series of measurements with decreasing amounts of 
sample for one randomly selected vial were performed. The following sample intakes were 
tested: 5 µL, 10 µL, 15 µL, 20 µL, 50 µL and 100 µL. For each sample intake, 3 subsamples 
of the vial were measured by UV spectrophotometry under repeatability conditions, and in a 
randomised manner. Each subsample was measured in triplicate. The measurement method 
was robust over the whole range of the sample intake tested and its repeatability was in the 
same range or better than the repeatability achieved during the material characterisation 
(Section 6). One technical outlier in the data of the minimum sample intake of 50 µL was 
observed due to an air bubble and excluded in the data sets before the data evaluation. 
The obtained data sets (all sample intakes taken together) were first evaluated whether they 
follow a normal, or at least unimodal distribution. This was done by normal probability plots 
and histograms (if the data do not follow at least a unimodal distribution, the calculation of 
standard deviations is doubtful or impossible). All results were normally and unimodally 
distributed. 
Furthermore, the results (all sample intakes taken together) were scrutinised for outliers 
using the single Grubbs-test. No outlier was detected. The minimum sample intake was 
established by comparison of variances obtained for 5 µL, 10 µL, 15 µL, 20 µL and 50 µL 
sample intakes with the variance obtained for 100 µL sample intake (F-test, 8 degrees of 
freedom, CI 95 %).  
The obtained results are presented in Annex C, indicating that the minimum sample intake 
representative of ERM-AD442k using UV spectrophotometry is 50 µL. The sample intake 
gives an acceptable repeatability, demonstrating that the within-vial inhomogeneity no longer 
contributes to analytical variation.  
 
4.2.2 Digital PCR 
Homogeneity/stability experiments were performed using a 68 µL sample intake for dPCR. 
The sample intake gives an acceptable repeatability, demonstrating that the within-vial 
inhomogeneity no longer contributes to analytical variation.  
 
In conclusion, the minimum amount of sample to be used is 50 µL for UV spectrophotometry 
and 68 µL for dPCR. 
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5 Stability 
Time, temperature and radiation were regarded as the most relevant influences on the 
stability of the material. In addition, materials are stored and dispatched in the dark, thus 
eliminating the possibility of degradation by UV radiation. Therefore, only the influences of 
time and temperature needed to be investigated.  
Stability testing is necessary to establish the conditions for storage (long-term stability) as 
well as the conditions for dispatch of the material to the customers (short-term stability). 
The stability studies were performed using an isochronous design [25]. In this approach, vials 
were stored for a specified length of time at different temperatures whereupon the vials were 
then moved to conditions where further degradation was assumed to be negligible (reference 
conditions). At the end of the isochronous storage, the vials were analysed simultaneously 
under repeatability conditions. Analysis of the material (after various exposure times and 
temperatures) under repeatability conditions greatly improves the sensitivity of the stability 
tests. 
 
5.1 Short-term stability study 
During the short-term stability study, vials were stored at -20 °C and 4 °C for 0, 1, 2 and 4 
weeks. The reference temperature was set to -70 °C. Five vials per storage time/temperature 
combination were selected using a random stratified sampling scheme. At the end of the 
stability study each vial was analysed 3 times by UV spectrophotometry and 10 times by 
dPCR (as described as in Section 1.3). The measurements were performed under 
repeatability conditions, and in a randomised sequence to be able to separate a potential 
analytical drift from a trend over storage time.  
The data were evaluated for each temperature individually. The results were screened for 
outliers using the single and double Grubbs test. Only one outlying individual result was 
found for the UV spectrophotometry at the temperature of 4 °C at 1 week. As no technical 
reason for the outlier could be found, all UV spectrophotometrical data were retained for 
statistical analysis and for the estimation of uSTS.  
Furthermore, the data were evaluated against storage time and regression lines of DNA 
mass concentration or DNA copy number concentration versus time were calculated. The 
slopes of the regression lines were tested for statistical significance (loss/increase due to 
shipping conditions). For the DNA mass concentration and the DNA copy number 
concentration, the slopes of the regression lines were not significantly different from zero (at 
a 99 % confidence level) at both -20 °C and 4 °C. The material was therefore shown to be 
stable for 4 weeks at -20 °C and 4 °C. The results of the measurements are shown in  
Annex D.  
It was concluded to ship the material frozen on dry ice to avoid thawing of the material during 
transport.  
 
5.2 Long-term stability study 
During the long-term stability study, vials were stored at -20 °C for 0, 4, 8, 12 and 18 months. 
The reference temperature was set to -70 °C. Five vials per storage time were selected using 
a random stratified sampling scheme. At the end of the stability study each vial was analysed 
3 times by UV spectrophotometry and 10 times by dPCR (as described as in Section 1.3). 
The measurements were performed under repeatability conditions, in a random sequence to 
be able to separate any potential analytical drift from a trend over storage time.  
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The results were screened for outliers using the single and double Grubbs test. Only one 
outlying individual result was found for the UV spectrophotometry. As no technical reason for 
the outliers could be found, all UV spectrophotometrical data were retained for statistical 
analysis and for the estimation of uLTS.  
Furthermore, the data were plotted against storage time and linear regression lines of DNA 
mass concentration or DNA copy number concentration versus time were calculated. The 
slope of the regression lines was tested for statistical significance (loss/increase due to 
storage conditions). For the DNA mass concentration and the DNA copy number 
concentration, the slopes of the regression lines were not significantly different from zero (at 
a 99 % confidence level) for -20 °C. The material should therefore be stored at -20 °C. The 
results of the long term stability measurements are shown in Annex E.  
 
5.3 Estimation of uncertainties 
Due to the intrinsic variation of measurement results, no study can entirely rule out 
degradation of materials, even in the absence of statistically significant trends. It is therefore 
necessary to quantify the potential degradation that could be hidden by the method 
repeatability, i.e. to estimate the uncertainty of stability. This means that even under ideal 
conditions the outcome of a stability study can only report that there was no detectable 
degradation during the timeframe studied. 
Uncertainties of stability during dispatch and storage were estimated as described in [26]. In 
this approach, the uncertainty of the linear regression line with a slope of zero was 
calculated. The uncertainty contributions usts and ults are calculated as the product of the 
chosen transport time/shelf life and the uncertainty of the regression lines as: 
( ) tt2irel,sts
t
tt
RSD
u ⋅
−
=
∑
 Equation 13 
( ) sl2irel,lts
t
tt
RSD
u ⋅
−
=
∑
 Equation 14 
RSD  relative standard deviation of all results of the stability study 
it  time elapse at time point i 
t  mean of all it  
ttt chosen transport time (1 week at -20 ºC) 
tsl chosen shelf life (18 months at -20 ºC) 
 
The following uncertainties were estimated: 
- usts,rel, the uncertainty of degradation during dispatch. This was estimated from the  
-20 °C study. The uncertainty describes the possible change during a dispatch at  
-20 °C lasting one week. 
- ults,rel, the stability during storage. This uncertainty contribution was estimated from 
the -20 °C study. The uncertainty contribution describes the possible degradation 
during 18 months storage at -20 °C.  
The results of these evaluations are summarised in Table 6. 
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Table 6: Uncertainties related to stability during dispatch (usts,rel calculated for a 
dispatch at -20 °C for 1 week) and storage (ults,rel calculated for storage at -20 °C for 18 
months). 
ERM-AD442k usts ,rel 
[%] 
ults,rel 
[%] 
UV spectrophotometry 0.12 0.23 
dPCR 0.60 1.99 
 
After the certification study, the material will be included in IRMM's regular stability 
monitoring programme to determine their future stability, once a year. 
 
5.4 Stability after freeze-thaw cycles 
 
Since DNA can degrade after freeze-thaw cycles, the DNA intactness and the consistency of 
the DNA mass concentration of ERM-AD442k were studied. The approach of this study was 
similar to the isochronous design. Two vials were submitted to a certain number of freeze-
thaw cycles (i.e. 0, 1, 3, 5, 7 and 10) and after each thawing session the vials were moved to 
the storage temperature (i.e. -20 °C). In total, 10 vials were selected based on a random 
stratified sampling scheme. The DNA intactness of each vial was analysed using gel 
electrophoresis. The DNA in none of the samples was found to be degraded (data not 
shown). 
In order to check the consistency of the DNA mass concentration over 10 freeze-thaw cycles, 
the DNA of each vial was measured 3 times by UV spectrophotometry under denatured 
condition (as described as in Section 1.3). The measurements were performed under 
repeatability conditions, in a random sequence to be able to separate any potential analytical 
drift from a trend over number of freeze-thaw cycles. The obtained data were screened for 
outliers using the single and double Grubbs test. No outlying individual results were found. 
The data were evaluated against number of freeze-thaw cycles and regression lines of DNA 
mass concentration versus number of freeze-thaw cycles were calculated. The slopes of the 
regression lines were tested for statistical significance (loss/increase due to freeze-thaw 
conditions). For the DNA mass concentration, the slopes of the regression lines were 
significantly different from zero (99 % confidence level) at 10 times of freezing and thawing, 
but not significantly different from zero (99 % confidence level) at 5 and 7 times of freezing 
and thawing. The results are given in Annex F. 
Therefore, it is recommended not to freeze-thaw ERM-AD442k more than 5 times in order to 
have consistency of the DNA mass concentration. Aliquoting ERM-AD442k is highly 
recommended after the first thawing and homogenisation. 
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6 Characterisation 
The material characterisation is the process of determining the property values of a reference 
material. 
 
The material characterisation was based on two inter-laboratory comparisons of expert 
laboratories that used two methods (UV spectrophotometry and/or dPCR). The DNA mass 
concentration of ERM-AD442k was measured by UV spectrophotometry. The measurements 
for DNA copy number concentration of ERM-AD442k was measured by dPCR using the 
BioMark™ HD System and the BioMark™ 12.765 Digital Arrays (both from Fluidigm). The 
inter-laboratory comparison approach allowed to negate laboratory bias, reducing the 
combined uncertainty. 
 
6.1 Selection of participants 
Five and seven laboratories were selected based on criteria that comprised both technical 
competence and quality management for UV spectrophotometry or dPCR measurements. 
Each laboratory was required to operate a quality system and to deliver documented 
evidence of its proficiency in the field of UV spectrophotometry and/or dPCR measurements. 
Having a formal accreditation was not mandatory, but meeting the requirements of ISO/IEC 
17025 was obligatory. 
 
6.2 Study setup 
 
6.2.1 Measurements using UV spectrophotometry 
Each laboratory received 6 vials of ERM-AD442k and was required to provide 36 results, 6 
per vial. The units for material characterisation were selected using a random stratified 
sampling scheme which covered the whole batch. The sample preparations and 
measurements had to be spread over at least two days to ensure intermediate precision 
conditions. The mean value of the 6 replicates of a vial was considered as one independent 
measurement result. 
 
6.2.2 Measurements using dPCR 
Each laboratory received 6 vials of ERM-AD442k and was required to provide 60 results, 10 
per vial. The vials for material characterisation were selected using a random stratified 
sampling scheme which covered the whole batch. The sample preparations and 
measurements had to be spread over at least two days and over different arrays to ensure 
intermediate precision conditions.  
All laboratories used the BioMark™ HD System and the BioMark™ 12.765 Digital Arrays 
(both from Fluidigm). The lambda DNA of each vial was first digested, followed by the 
preparation of two independently gravimetrical dilution series. The final DNA concentration 
solution of each dilution series was analysed 5 times in a simplex dPCR. These 5 replicates 
were spread at random over different arrays (as described as in Section 1.3). The mean 
value of the 10 replicates of a vial was considered as one independent measurement result. 
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6.3 Methods used 
All laboratories used the same methods, i.e. UV spectrophotometry and dPCR, for DNA 
mass concentration measurements and DNA copy number concentration measurements, 
respectively (Section 1.3).  
All types of instruments used during the characterisation study are summarised in Annex G. 
The laboratory code (e.g. L1) is a random number and does not correspond to the order of 
laboratories in Section 0. When a laboratory applied 2 methods, the method-code is added to 
the laboratory code to specify the method used for a dataset (e.g. L1-UV). 
 
6.4 Evaluation of results 
The characterisation study resulted in 7 datasets for UV spectrophotometry and in 5 datasets 
for dPCR. The technical and statistical evaluations of these datasets were performed by 
IRMM. All individual results of the participants, grouped per method, are displayed in a 
tabular form and in a graph in Annex H.  
 
6.4.1 Technical evaluation 
The data were first assessed for compliance with the analysis protocol and for their validity 
based on technical reasons. When excluding results, a technical reason was required. The 
following criteria were considered during the evaluation for UV spectrophotometry and dPCR. 
UV spectrophotometry: 
- compliance with the analysis protocol: sample preparations and measurements of 
replicates performed randomly and on different days 
- correctness of the dilutions steps: all dilutions steps had to be prepared 
gravimetrically and masses had to be recorded 
- correctness of preparing the blank solution 
- correct setting of the baseline  
- RSD between replicates over the 6 vials on one day should be below 5 % 
 
dPCR: 
- compliance with the analysis protocol: sample preparations and measurements of 
replicates performed randomly, on different days and on different arrays 
- correctness of the dilutions steps: all dilutions steps had to be prepared 
gravimetrically and masses had to be recorded 
- homogeneous distribution of digested lambda DNA over a panel 
- RSD between replicates of 1 dilution series over the 6 vials should be below 15 % 
 
Based on the above criteria, the following datasets were rejected as not technically valid 
(Table 7). 
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Table 7: Datasets that showed non-compliances with the analysis protocol and 
technical specifications, and action taken. 
Measurement 
method 
Lab-method 
code 
Description of problem Action taken 
UV 
spectrophotometry 
L6-UV Technical problem with one of 
the replicates (reported by 
laboratory) 
Result of this 
replicate was not 
used 
UV 
spectrophotometry 
L7-UV Technical problem (baseline 
was not correctly set, resulting 
in an absorbance shift in the 
measurements of the 2 days) 
Not used for 
evaluation 
dPCR  L5-dPCR Technical problem (RSD  
> 15 % in 1 dilution series) 
Results of 1 dilution 
series was not used 
for evaluation 
 
6.4.2 Statistical evaluation 
The valid datasets were assessed for normality of dataset means using kurtosis/skewness 
tests and normal probability plots. They were assessed for outlying means using the Grubbs 
test and using the Cochran test for outlying standard deviations (both at a 99 % confidence 
level). Standard deviations within (swithin) and between (sbetween) laboratories were calculated 
using one-way ANOVA. The results of these evaluations are shown in Table 8a & 8b. 
 
Table 8a: Statistical evaluation of the technically valid datasets for UV 
spectrophotometry. p: number of technically valid datasets 
UV spectrophotometry  P Statistical parameters  
Mean1) 
[ng/µL] 
s 
[ng/µL] 
sbetween 
[ng/µL] 
swithin 
[ng/µL] 
ERM-AD442k 6 57.53 0.98 0.95 0.59 
1)
 including less than 0.02 ng/µL of non-lambda DNA (i.e. E. coli DNA). 
 
Table 8b: Statistical evaluation of the technically valid datasets for dPCR. 
p: number of technically valid datasets 
dPCR  
 
p Statistical parameters  
Mean 
[cp/µL] 
s 
[cp/µL] 
sbetween 
[cp/µL] 
swithin 
[cp/µL] 
ERM-AD442k 5 1.20 x 109 1.43 x 108 1.41 x 108 4.82 x 107 
 
The laboratory means follow a normal distribution. None of the data contains outlying means 
and variances. The datasets were therefore consistent and the mean of laboratory means 
was a good estimate of the true value.  
The uncertainty relating to the characterisation is estimated as the standard error of the 
mean of laboratory means (Table 9a & 9b). 
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Table 9a: Uncertainty of characterisation for UV spectrophotometry. 
UV 
spectrophotometry  
p Mean1) 
[ng/µL] 
s 
[ng/µL] 
uchar 
[ng/µL] 
uchar,rel 
[%] 
ERM-AD442k 6  57.53 0.98 0.40 0.69 
1)
 including less than 0.02 ng/µL of non-lambda DNA (i.e. E. coli DNA). 
 
Table 9b: Uncertainty of characterisation for dPCR. 
dPCR p Mean 
[cp/µL] 
s 
[cp/µL] 
uchar 
[cp/µL] 
uchar,rel 
[%] 
ERM-AD442k 5 1.20 x 109 1.43 x 108 6.36 x 107 5.32 
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7 Value Assignment 
Certified and indicative values were assigned. 
Certified values are values that fulfil the highest standards of accuracy. Procedures at IRMM 
generally require pooling of not less than 6 datasets to assign certified values. Full 
uncertainty budgets in accordance with the 'Guide to the Expression of Uncertainty in 
Measurement' [4] were established. ERM-AD422k was certified for its DNA mass 
concentration by UV spectrometry. 
Indicative values are values where either the uncertainty is deemed too large or where too 
few independent datasets (i.e. less than 6 datasets) were available to allow certification. In 
the case of ERM-AD442k only 5 valid datasets for dPCR were obtained and the estimated 
uncertainty for the copy number concentration measurements found to be too large for 
certification. Consequently an indicative value was given. Uncertainties were evaluated 
according to the same rules as for the certified value. 
 
7.1 Certified value and its uncertainty 
The unweighted mean of the means of the accepted datasets as shown in Table 9a was 
assigned as certified value. 
The assigned uncertainty consists of uncertainties relating to characterisation, uchar  
(Section 0.4), to potential between-unit inhomogeneity, ubb (Section 4.1), to potential 
degradation during transport, usts (Section 5.3), and to potential degradation during long-term 
storage, ults (Section 0.3).  
The uncertainty relating to degradation during transport (usts) was not considered in the 
combined uncertainty, as the samples will be transported on dry ice, as the storage 
temperature is -20 °C ± 5 °C and as this uncertainty is considered as negligible (i.e. less than 
one third of the highest uncertainty contribution) in accordance with the Guide to the 
Expression of Uncertainty in Measurement (GUM) [4].  
The uncertainty of the long-term stability (ults) has been considered in the combined 
uncertainty. These different contributions were combined to estimate the relative expanded 
uncertainty of the certified value (UCRM, rel) with a coverage factor k as:  
2
rel lts,
2
rel bb,
2
rel char,rel CRM, uuukU ++⋅=  Equation 15 
- uchar was estimated as described in Section 6.4  
- ubb was estimated as described in Section 4.1 
- ults was estimated as described in Section 5.3 
Because of the sufficient numbers of the degrees of freedom of the different uncertainty 
contributions for UV spectrophotometry, a coverage factor k of 2 was applied, to obtain the 
expanded uncertainty. The certified value and its uncertainty are summarised in Table 10. 
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Table 10: Certified value and its uncertainty for ERM-AD442k using UV 
spectrophotometry. 
 Certified value1) 
[ng/µL] 
uchar, rel 
 
[%] 
ubb, rel 
[%] 
ults, rel 
[%] 
UCRM, rel  
[%] 
UCRM 2)  
[ng/µL] 
Lambda DNA 57.5 0.69 0.58 0.23 1.85 1.1 
1)
 including less than 0.02 ng/µL of non-lambda DNA (i.e. E. coli DNA) 
2)
 expanded (k = 2) and rounded uncertainty 
 
As described in the purity assessment Section (i.e. Section 3.3.2.3), a negligible percentage 
of the host DNA (i.e. 0.13 %) was found by qPCR using E. coli-specific primers and probes. 
This percentage represents a DNA copy number concentration of host DNA sequences (i.e. 
1.57 x 106 cp/µL), converted to a DNA mass concentration of 0.02 ng/µL (using Equation 4).  
 
7.2 Indicative value and its uncertainty 
An indicative value was assigned for the DNA copy number concentration using dPCR as the 
expanded combined uncertainty is rather large and because the number of valid datasets is 
below 6. However, the results were regarded as sufficiently trustworthy to assign as an 
indicative value. An indicative value may not be used as a certified value. The uncertainty 
budget was calculated as for the certified value and is listed together with the assigned value 
in Table 11. 
 
For dPCR, the effective number of degrees of freedom was calculated to be 7, using the 
Welch-Sattertwaithe equation in accordance with the Guide to the Expression of Uncertainty 
in Measurement (GUM) [4], and correspondingly a factor k of 2.36 was chosen. 
 
Table 11: Indicative value and its uncertainty for ERM-AD442k using dPCR. 
 Indicative value 
[cp/µL] 
uchar, rel 
 
[%] 
ubb, rel 
[%] 
ults, rel 
[%] 
UCRM, rel  
[%] 
UCRM 1) 
[cp/µL] 
Lambda DNA   1.20 x 109 5.32 1.75 1.99 14.01 0.17 x 109 
1)
 expanded (k = 2.36) and rounded uncertainty 
 
Using Equation 4 the indicative value for DNA copy number concentration determined by 
dPCR is converted into DNA mass concentration, the indicative value for DNA mass 
concentration using dPCR is 59.54 ng/µL and the UCRM is 8.34 ng/µL. 
 
Another dPCR assay (named as lambda DNA assay 2 in Annex Table A4) was performed 
targeting another region of the lambda DNA sequence. This DNA sequence region has the 
same GC content as the DNA sequence region that was targeted by primers and probe given 
in Annex Table A1 (which is the same as lambda DNA assay 1 in Annex Table A4). The 
same restriction enzyme was used which is Taq(α)I. One vial was analysed according to 
Section 1.3.1 and having 5 replicates. The results were analysed using ERM Application 
Note 1 (www.erm-crm.org, [27]), revealing no bias between the measurements of lambda 
DNA assay 2 and the indicative value of the DNA copy number concentration by dPCR.  
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8 Metrological traceability and applicability of  
ERM-AD442k 
8.1 Metrological traceability  
Identity 
Identity was confirmed by two expert sequencing service companies using two independent 
NGS methods: i.e. an Illumina platform based on base-specific fluorescence and a GS Junior 
platform (Roche) based on pyrosequencing. NGS methods are high-throughput and deep 
sequencing methods, where multiple DNA fragments are sequenced simultaneously and in 
multiple times. The participants used different methods for the sample preparation as well as 
for the final determination, demonstrating absence of measurement bias. The identity of the 
measurand is therefore structurally defined and independent of the measurement method. 
 
Quantity value 
The DNA mass concentration of ERM-AD442k is a method-defined measurand and has 
been obtained by UV spectrophotometry. The DNA copy number concentration of  
ERM-AD442k is a method-defined measurand and has been obtained by dPCR using 
primers, probe and PCR conditions shown in Annex Table A1 – A3. Traceability of the results 
is based on the traceability of all relevant input factors. Instruments in individual laboratories 
were verified and calibrated with tools ensuring traceability to the SI. Consistency within each 
of the two inter-laboratory comparisons demonstrates that all relevant input factors were 
covered. As the assigned values are combinations of agreeing results, individually traceable 
to the SI, the assigned quantity values themselves are also traceable to the SI. 
 
In conclusion, the measurand is method-defined as the certified value was measured by UV 
spectrophotometry using an absorption coefficient for denatured DNA of 37 ng/µL [19] in 
Equation 1 and as the indicative value was measured by digital PCR. 
 
8.2 Applicability of ERM-AD442k 
The applicability of a CRM defines its fitness for use. When applicability of a CRM is not 
established, the results from routinely used applications cannot be legitimately compared 
with the certified value to determine whether a bias does not exist in calibration, nor can the 
CRM be used as a calibrant.  
 
ERM-AD442k is prepared from lambda DNA and the analytical behaviour will be the same as 
for a routine sample of lambda DNA. For other types of samples other than lambda DNA the 
applicability has to be assessed. 
 
This CRM is mainly used as a calibrant to set up calibration curves. Ideally, a calibration 
curve contains several different concentrations by diluting the CRM to the desired 
concentrations. A fit-for-purpose test was performed to compare calibration curves prepared 
with ERM-AD442k (with certified DNA mass concentration) and with a commercial lambda 
DNA (with a stated DNA mass concentration) using a Quant-iTTM PicoGreen dsDNA assay 
(Life Technologies). From a lambda DNA solution with a DNA mass concentration of 2 ng/µL, 
5 final DNA mass concentrations (0.10 ng/µL, 0.25 ng/µL, 0.50 ng/µL, 0.75 ng/µL and  
0.90 ng/µL) were prepared and used in duplicate to construct one calibration curve. Four 
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independent calibration curves were prepared with the ERM-AD442k as well as with the 
commercial lambda DNA. The results of the lambda DNA CRM and the commercial lambda 
DNA are compiled in Annex I. The coefficient of determination of the linear regression (r2) is 
0.9902 for the calibration curve of ERM-AD442k and 0.9900 for the calibration curve of the 
commercial lambda DNA. Both results are therefore comparable. The Quant-iTTM PicoGreen 
dsDNA assay demonstrated that the ERM-AD442k lambda DNA in solution is suitable for 
using as a calibrant, while applying the certified DNA mass concentration value of the UV 
spectrophotometry. 
  
 37 
9 Instructions for use 
9.1 Safety information 
The usual laboratory safety measures apply. 
 
9.2 Storage conditions 
The materials shall be stored at -20 °C ± 5 °C in the dark.  
Providing microbial contamination was excluded during the production, the lambda DNA in 
solution can be used for numerous experiments. As outlined in the Certification Report, the 
material should not exceed more than 5 freeze-thaw cycles to avoid inconsistency in the 
DNA mass concentrations. The material can also be stored at 4 °C for 4 weeks as changes 
to the certified DNA mass concentration observed during that period are not significant. It is 
advisable to close the vial with the original screw cap after use. The lambda DNA in solution 
should not be exposed to direct sun light or any other UV radiation. 
Please note that the European Commission cannot be held responsible for changes that 
happen during storage of the material at the customer's premises, especially of opened vials. 
 
9.3 Preparation and use of the material 
When the vial of lambda DNA solution is used for the first time, the material should be 
prepared as follows. Thaw the contents of the vial by leaving the vial at 4 °C overnight. Bring 
the vial and its contents to room temperature followed by homogenising the contents of the 
vial thoroughly and gently for 10 min. This homogenising process needs to be repeated once 
more. 
It is recommended not to freeze-thaw ERM-AD442k more than 5 times in order to have 
consistency in the DNA mass concentration. Therefore, aliquoting ERM-AD442k is highly 
recommended after the first thaw and after homogenising thoroughly. 
 
The vials should be opened and handled under a laminar flow to reduce the risk of 
contamination. 
 
9.4 Minimum sample intake 
The minimum sample intake is 50 µL for UV spectrophotometry and 68 µL for dPCR.  
 
9.5 Use of the certified value 
The main purpose of the material is to use as a calibrant. The material and its certified value 
are intended to be used for the calibration of DNA quantification methods, quality control and 
assessment of method performance, i.e. for checking accuracy of analytical results or 
calibration, since this lambda DNA calibrant has a wide and versatile use. As any reference 
material, it can also be used for control charts or validation studies. 
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Use as a calibrant 
It is recommended to use this material as calibrant. The uncertainty of the certified value 
shall be taken into account in the estimation of the measurement uncertainty.  
 
Comparing an analytical result with the certified value 
A result is unbiased if the combined standard uncertainty of measurement and certified value 
covers the difference between the certified value and the measurement result (see also ERM 
Application Note 1, www.erm-crm.org [27]).  
For assessing the method performance, the measured values of the CRMs are compared 
with the certified values. The procedure is described here in brief:  
- Calculate the absolute difference between mean measured value and the certified 
value (∆meas). 
- Combine measurement uncertainty (umeas) with the uncertainty of the  
certified value (uCRM): 22 CRMmeas uuu +=∆  
- Calculate the expanded uncertainty (U∆) from the combined uncertainty (u∆) using an 
appropriate coverage factor, corresponding to a level of confidence of approximately 
95 % 
- If ∆meas ≤ U∆ no significant difference exists between the measurement result and the 
certified value, at a confidence level of about 95 %. 
 
Use for quality control and in quality control charts 
The materials can be used for quality control charts and also as a quality control material. All 
vials can be treated as containing the same concentration of solution as a contribution has 
been included in the combined uncertainty to represent any between-vial inhomogeneity. 
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Annexes 
 
Annex A: Description of the (d)qPCR technique 
The DNA copy number concentration of lambda DNA in ERM-AD442k has been determined 
by dPCR using the protocol described below. After the lambda DNA in each ERM-AD442k 
vial was digested with the restriction enzyme Taq(α)I, two independent DNA dilution series 
were prepared gravimetrically. For each dilution series, 25 µL of digested ERM-AD442k was 
gravimetrically diluted with T1E0.01 buffer to obtain DNA samples at a nominal final DNA copy 
number concentration of 447 cp/µL. A volume of 3.54 µL of this diluted digested DNA sample 
was further mixed with 5.46 µL pre-sample mix solution. This mixture, having a total volume 
of 9 µL, was loaded in 1 panel of the BioMark™ 12.765 digital arrays. The pre-sample mix 
contained 20x GE sample loading reagent (Fluidigm) and 2x TaqMan Universal PCR 
MasterMix (Applied BioSystems), of which the concentration was used according to the 
manufacturer. The concentration of the primers and probe in the pre-sample mix are given in 
Table A1. The dPCR was performed according to the condition specifications in Table A2. 
The dPCR runs were analysed with the Fluidigm Digital PCR Analysis software using either 
the parameters in Table A3 or manual calling.  
 
Table A1. Primers and probe used to amplify the lambda DNA fragment in a simplex dPCR. 
FAM: fluorescein amidite. BHQ1: Black Hole Quencher 1. *Reference sequence is the 
complete genome of phage lambda NC_001416.1 
Primer/ 
probe 
Coordinates in 
reference 
sequence* 
Sequence (5’ to 3’) Concentration in PCR [nM] 
Amplicon 
size [bp] 
Forward 
primer 
5845…5863 TGCAATGACCCCGCTGATG 500 
147 
Reverse 
primer 
5931…5955 CGGAACGTGCCGGACTTG 500 
Probe 5974…5991 6-FAM-
CTGGTCTGGTCAGCAGCAACCGCAA
-BHQ1 
100 
 
Table A2. Thermal cycling protocol used for the simplex dPCR amplifying lambda DNA 
target. 
Name Phase Time [seconds] Temperature [°C] Repeats 
Uracil-N-glycosylase (UNG)  
and Hot start 
UNG 120 50 1 
Hot start 600 95  
PCR cycle 
 
Denaturation 15 95 45 
Annealing 60 60  
Image should be captured after the end of each cycle. 
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Table A3. Digital PCR analysis parameters 
Quality threshold 0.05 
Baseline Correction linear 
Ct threshold method Auto (Global) 
Target Ct Range 10-45 
 
 
The purity assessment of ERM-AD442k was performed by NGS and qPCR. For the latter, 
ABI Prism 7900HT (Applied BioSystems) was used. Table A4 shows the primers and probes 
used for the quantification of the host (E. coli) DNA fragments. Brilliant II QPCR Master Mix 
(Agilent, Diegem, BE) was used according to the manufacturer. The PCR conditions were 
the same as described in Table A2. The qPCR runs were analysed with the Sequence 
Detection Systems software version 2.4.1 (Applied BioSystems).  
 
Table A4. Primers and probe used to amplify a lambda DNA fragment and an E. coli DNA 
fragment in a simplex qPCR. FAM: fluorescein amidite. BHQ1: Black Hole Quencher 1. HEX: 
hexachlorofluorescein. 
Primer/probe Sequence (5’ to 3’) Concentration in PCR [nM] 
Amplicon 
size [bp] 
Lambda DNA assay 1   
Forward primer TGCAATGACCCCGCTGATG 500 
147 Reverse primer CGGAACGTGCCGGACTTG 500 
Probe 6-FAM-CTGGTCTGGTCAGCAGCAACCGCAA-
BHQ1 
100 
Lambda DNA assay 2   
Forward primer TGCGCTGTATGCCGGTATG 500 
188 Reverse primer GTTGTTCGGGTCAATCCAGTTC 500 
Probe 5-HEX-CCTCAACGGCATTATGGCGGTCCTT-
BHQ1 
300 
E. coli assay 1 
 
  
Forward primer CCATCTTCCAGCCCCTCTTC 900 
74 Reverse primer CTGAATTCCGCTTTTAAACCTTCT 900 
Probe 6-FAM- ACGTCGAATCGCCTCTGGCTGATC-
BHQ1 
200 
E. coli assay 2 
 
  
Forward primer GCGAACCGTAGCCATCCA 900  
Reverse primer AACTGCATGCGGCACTACTG 900 75 
Probe 6-FAM-TTCCGCTTTAACCCCGCGTTGC-
BHQ1 
200 
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Annex B: Results of the homogeneity measurements 
 
 
Figure B1. Homogeneity study using UV spectrophotometry for DNA mass concentration in 
ERM-AD442k: the vial mean ± the confidence interval of the means (calculated according to 
Equation 16). 
 
           
n
s
*tCI wb2%;95means =                                         Equation 16 
meansCI  confidence interval of the means 
n number of vials analysed 
t95%;2 Student value for degrees of freedom of swb and a confidence level of 95% 
swb standard deviation within groups from one way ANOVA for all vials 
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Figure B2. Homogeneity study using dPCR for DNA copy number concentration in  
ERM-AD442k: the vial mean ± the confidence interval of the means (calculated according to 
Equation 16). 
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Annex C: Results of the minimum sample intake measurements  
 
Table C1: Results of the statistical evaluation of the minimum sample intake study for UV 
spectrophotometry at a 95 % confidence level 
Sample intake 
[µL] 
Measurement results 
[ng/µL] 
Standard deviation 
[ng/µL] 
Variances 
[ng/µL] 
5 52.43 2.60 6.74 
10 55.73 2.31 5.34 
15 56.46 1.64 2.70 
20 56.83 1.19 1.41 
50 56.23 0.39 0.15 
100 57.16 0.22 0.05 
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Annex D: Results of the short-term stability measurements 
 
 
Figure D1. Short-term stability study at -20 °C using UV spectrophotometry for DNA mass 
concentration in ERM-AD442k. 
 
 
 
Figure D2. Short-term stability study at 4 °C using UV spectrophotometry for DNA mass 
concentration in ERM-AD442k. 
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Figure D3. Short-term stability study at -20 °C using dPCR for DNA copy number 
concentration in ERM-AD442k. 
 
 
 
Figure D4. Short-term stability study at 4 °C using dPCR for DNA copy number concentration 
in ERM-AD442k. 
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Annex E: Results of the long-term stability measurements 
 
 
Figure E1. Long-term stability study at -20 °C using UV spectrophotometry for DNA mass 
concentration in ERM-AD442k. 
 
 
 
Figure E2. Long-term stability study at -20 °C using dPCR for DNA copy number 
concentration in ERM-AD442k. 
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Annex F: Results of the freeze-thaw study 
 
 
Figure F. UV spectrophotometrical analyse of the consistency of DNA mass concentration in 
ERM-AD442k over 10 freeze-thaw cycles. 
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Annex G: Summary of methods used in the characterisation study 
 
Table G. Summary of instruments used in the characterisation study per laboratory. n.a.: not 
applicable. 
Laboratory 
Instrument used for 
UV spectrophotometry dPCR 
L1 BioPhotometer (Eppendorf) 
BioMark™ HD System 
(Fluidigm) 
L2 UV-2450 UV-Vis spectrophotometer (Shimadzu)  
L3 Biotek Synergy MX (Biotek) 
L4 Cary 4000 UV-Vis spectrophotometer (Agilent) 
L5 Infinite 200 (Tecan) 
L6 8453 DAD-UV spectrophotometer (Agilent) n.a. 
L7 UV/Vis spectrophotometer UV2 (Unicam) n.a. 
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Annex H: Results of the characterisation measurements 
 
Table H1. Results of the characterisation study of the DNA mass concentration in  
ERM-AD442k using UV spectrophotometry 
Laboratory number 
DNA mass concentration [ng/µL] Mean Uncertainty (k = 2) 
Vial 1 Vial 2 Vial 3 Vial 4 Vial 5 Vial 6 [ng/µL] [ng/µL] 
L1 55.42 58.04 57.58 56.94 57.47 57.37 57.02 0.34 
L2 58.29 58.88 57.31 59.09 58.87 58.75 57.07 0.29 
L3 56.76 56.95 56.79 56.87 57.53 57.54 58.94 0.48 
L4 59.21 59.18 59.27 59.59 58.15 58.26 57.14 0.75 
L5 56.56 56.88 56.53 57.29 57.32 57.52 56.46 0.32 
L6 57.03 56.36 55.95 56.54 56.72 56.15 58.53 0.54 
         
Results not used for certification 
L7 51.87 53.20 52.20 53.20 52.67 52.15 52.55 0.46 
 
 
 
Figure H1. Results of the characterisation study of the DNA mass concentration in  
ERM-AD442k using UV spectrophotometry. The error bars represent expanded 
uncertainties. The solid line represents the certified value (the mean of laboratory means), 
while the broken lines represent the expanded uncertainty of the certified value. 
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Table H2. Results of the characterisation study of the DNA copy number concentration in 
ERM-AD442k using dPCR 
Laboratory 
number 
DNA copy number concentration [cp/µL] Mean Uncertainty (k = 2) 
Vial 1 [ng/µL] [ng/µL] Vial 4 Vial 5 Vial 6 [cp/µL] [cp/µL] 
L1 1.25 x 109 
1.31 x 
109 
1.38 x 
109 
1.43 x 
109 
1.40 x 
109 
1.37 x 
109 
1.36 x 
109 5.09 x 10
7 
L2 1.01 x 109 
1.00 x 
109 
1.00 x 
109 
1.01 x 
109 
0.99 x 
109 
0.95 x 
109 
0.99 x 
109 1.73 x 10
7 
L3 1.20 x 109 
1.33 x 
109 
1.33 x 
109 
1.32 x 
109 
1.32 x 
109 
1.31 x 
109 
1.30 x 
109 3.90 x 10
7 
L4 1.19 x 109 
1.23 x 
109 
1.15 x 
109 
1.19 x 
109 
1.18 x 
109 
1.19 x 
109 
1.19 x 
109 2.25 x 10
7 
L5 1.15 x 109 
1.19 x 
109 
1.10 x 
109 
1.17 x 
109 
1.22 x 
109 
1.04 x 
109 
1.15 x 
109 5.31 x 10
7 
 
 
 
Figure H2. Results of the characterisation study of the DNA copy number concentration in 
ERM-AD442k using dPCR. The error bars represent expanded uncertainties. The solid line 
represents the indicative value (the mean of laboratory means), while the broken lines 
represent the expanded uncertainty of the indicative value. 
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Annex I: Applicability of CRM 
 
 
Figure I1. Comparable results between ERM-AD442k and a commercial lambda DNA 
solution using Quant-iTTM PicoGreen dsDNA assay. The solid line is the regression line of 
ERM-AD442k and the dashed line is the regression line of the commercial lambda DNA 
solution. The solid error bars are the standard deviations of ERM-AD442k and the dashed 
error bars are the standard deviations of the commercial lambda DNA solution. 
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Figure I2. Comparable results between ERM-AD442k and a commercial lambda DNA 
solution using Quant-iTTM PicoGreen dsDNA assay. The solid error bars are the standard 
deviations of ERM-AD442k and the dashed error bars are the standard deviations of the 
commercial lambda DNA solution. 
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